The use of a Dabigatran-Specific Reversal Agent: Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective

Saved in:
Bibliographic Details
Published inValue in health Vol. 19; no. 7; p. A606
Main Authors Jamet, N, Bourguignon, S, Le Lay, K
Format Journal Article
LanguageEnglish
Published 01.11.2016
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
DOI:10.1016/j.jval.2016.09.1493